Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
175.64B | 181.64B | 184.72B | 142.20B | 116.07B | 119.67B | Gross Profit |
28.12B | 31.26B | 33.75B | 24.40B | 16.89B | 18.21B | EBIT |
4.72B | 8.90B | 12.68B | 6.43B | 1.57B | 2.55B | EBITDA |
14.28B | 17.62B | 19.99B | 12.27B | 6.72B | 7.88B | Net Income Common Stockholders |
7.41B | 8.25B | 7.81B | 7.90B | 1.70B | 2.81B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
29.19B | 29.49B | 25.67B | 18.30B | 20.81B | 21.06B | Total Assets |
202.52B | 206.94B | 192.34B | 170.11B | 156.01B | 139.43B | Total Debt |
27.57B | 35.62B | 33.46B | 25.56B | 25.61B | 25.65B | Net Debt |
-1.42B | 6.23B | 8.39B | 7.76B | 5.84B | 7.21B | Total Liabilities |
84.35B | 93.10B | 90.99B | 75.46B | 66.74B | 61.98B | Stockholders Equity |
114.81B | 110.90B | 98.84B | 92.41B | 87.19B | 75.59B |
Cash Flow | Free Cash Flow | ||||
6.10B | 4.04B | -164.00M | -2.63B | 1.17B | -2.08B | Operating Cash Flow |
18.41B | 16.32B | 9.19B | 5.26B | 7.09B | 4.81B | Investing Cash Flow |
-8.38B | -12.73B | -8.12B | -5.97B | -4.01B | -4.77B | Financing Cash Flow |
-11.91B | -571.00M | 5.43B | -2.30B | -2.13B | 4.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $1.95T | 14.10 | 13.37% | 1.96% | 10.79% | 35.98% | |
74 Outperform | ¥82.02B | 14.06 | 2.89% | -5.67% | -21.99% | ||
74 Outperform | ¥28.68B | 9.60 | 4.65% | 9.31% | -16.41% | ||
73 Outperform | ¥292.99B | 7.68 | 9.28% | 4.27% | 2.73% | ― | |
66 Neutral | ¥814.88B | 50.10 | 2.10% | 2.64% | -6.57% | -76.15% | |
60 Neutral | $11.64B | 10.63 | -6.94% | 2.93% | 7.63% | -11.15% | |
57 Neutral | €293.79B | ― | -2.79% | 0.68% | 11.88% | -227.11% |